Immatics IMTX
NASDAQ IMTX
$8.56 +0.06 (+0.71%)
At close: Sep 29, 2026 · 4:00 PM EDT

Immatics (IMTX) EV to EBIT (2022)

Updated

Immatics' EV to EBIT came in at 8.05 for Q4 2022, down 52.8% from the prior quarter.

Analysis

Immatics (IMTX) EV to EBIT (2022) Analysis & Trends

For FY2022, Immatics' EV to EBIT was 9.06.

  • Business Quant data shows IMTX's EV to EBIT at 17.05 (Q3 2022), 14.85 (Q2 2022) and 68.50 (Q1 2022) in the three quarters before Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Immatics 1.14 Bn -898.62 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 8.05
Sep 30, 2022 17.05
Jun 30, 2022 14.85
Mar 31, 2022 68.50
API Access

Immatics EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=IMTX&period=max&api_key=YOUR_API_KEY